A local firm is getting a leg up from the government of Quebec in its mission to restore vision to the blind.
Ottawa-based iBIONICS is developing a patented technology that could help blind people to see by capturing visual data with a specialized pair of glasses and sending those electronic signals to the brain through a diamond-based implant in the eye.
The Quebec government announced Thursday the startup will receive a total of $438,400 in financing from the Quebec Life Sciences Strategy. The 10-year, $205-million fund is meant to foster innovation in the province’s health-care system and set firms up to attract private investment down the line.
(Sponsored)
In a tough economy, investing in community is more important than ever
When finances are tight, it might seem counterintuitive to give back, but supporting our most vulnerable neighbours this holiday season can actually help businesses weather their own challenges. At United
Inspired by love and loss, donor Tom Moore triples Giving Tuesday donations
For Tom Moore, a retired tech executive and longtime Ottawa resident, giving back to The Ottawa Hospital isn’t just a gesture of generosity. It’s personal. Tom grew up on a
In a statement, iBIONICS CEO and co-founder Suzanne Grant said the extra cash will set the firm up to raise an equity round later this fall. Coming in to 2018, the firm had raised roughly US$4 million between grants and public and private funding sources.
“If you have a highly-purposed mission within your project, the level of support you get is very different,” Grant told Techopia Live earlier this year.
